eli lilly glp 1 market share and Novo Nordisk are dominating the GLP-1 drug world — but why is demand skyrocketing?💊🚀 Swipe left to find out ⬅️ #GLP1 #WeightLossDrugs # EliLilly #NovoNordisk #Ozempic #Mounjaro #ObesityCrisis #HealthcareTrends #INDmoney # Lilly orforglipron oral GLP-1 phase

Cornu M, Modi H, Kawamori D, Kulkarni RN, Joffraud M, Thorens B: Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression

Arjinpathana N, Asawanonda P

If you want maximum weight loss Retatrutide is the current frontrunner for maximum weight loss in clinical trials

On the other hand, semaglutide and tirzepatide produce dramatically more weight loss than Pendulum

For example, in tendon fibroblast cells, BPC-157 dramatically increases phosphorylation (activation) of FAK and paxillin, leading to more cell migration and survival at injury sites

Some offer simple medication-only plans, while others bundle additional services to increase convenience and support